2026Q1
| Insider | Role (last 12 mo) | Shares held | Filed at |
|---|---|---|---|
| Shendelman Shoshana | CEO | 1,870,771 | Aug 14, 2024 |
| Funtleyder Leslie D. | Officer | 1,190,459 | Oct 1, 2025 |
| Johnson John | — | 1,000,000 | Dec 20, 2024 |
| Perfetti Riccardo | Chief Medical Officer | 890,409 | Mar 6, 2025 |
| Bailey Evan Prescott | — | 841,669 | Jun 17, 2025 |
| Exec date | Filing date | Insider | Role | Signal | Confidence | Shares | % of shares | Under plan? | Amount (USD) |
|---|---|---|---|---|---|---|---|---|---|
| Feb 3, 2026 | Feb 4, 2026 | Kanter Stacy J. | Director | Neutral | 27.5 | -65,000 | -100.00% | ✗ | - |
| Dec 19, 2025 | Feb 3, 2026 | Hooks Corwin Dale | Chief Commercial Officer | Neutral | 27.5 | -555,753 | -100.00% | ✗ | - |
| Dec 19, 2025 | Feb 3, 2026 | Chinoporos Constantine | Officer | Neutral | 27.5 | -619,611 | -100.00% | ✗ | - |
| Feb 3, 2026 | Feb 3, 2026 | SKYLER JAY S | Director | Neutral | 27.5 | -65,000 | -100.00% | ✗ | - |
| Dec 19, 2025 | Feb 3, 2026 | Funtleyder Leslie D. | CFO | Neutral | 27.5 | -1,340,459 | -100.00% | ✗ | - |
| Dec 19, 2025 | Feb 3, 2026 | Bailey Evan Prescott | Chief Medical Officer | Neutral | 27.5 | -859,316 | -100.00% | ✗ | - |
| Feb 3, 2026 | Feb 3, 2026 | Lerner Teena | Director | Neutral | 27.5 | -105,422 | -100.00% | ✗ | - |
| Jan 1, 2026 | Jan 2, 2026 | Funtleyder Leslie D. | CFO | Neutral | 90.0 | +150,000 | 12.60% | ✗ | - |
| Dec 16, 2025 | Dec 18, 2025 | Kanter Stacy J. | Director | Sell | 27.5 | -43,000 | -39.81% | ✗ | $4.8K |
| Oct 1, 2025 | Oct 1, 2025 | Funtleyder Leslie D. | CFO | Neutral | 90.0 | +150,000 | 14.42% | ✗ | - |
| Jun 9, 2025 | Jul 3, 2025 | Funtleyder Leslie D. | CFO | Neutral | 90.0 | +300,000 | 47.09% | ✗ | - |
| Jun 15, 2025 | Jun 17, 2025 | Bailey Evan Prescott | Chief Medical Officer | Neutral | 90.0 | +300,000 | 55.38% | ✗ | - |
| Jun 17, 2025 | Bailey Evan Prescott | Chief Medical Officer | Neutral | 52.5 | - | 0.00% | ✗ | - | |
| Jun 9, 2025 | Jun 11, 2025 | Lerner Teena | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jun 9, 2025 | Jun 11, 2025 | Kanter Stacy J. | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jun 9, 2025 | Jun 11, 2025 | SKYLER JAY S | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Mar 24, 2025 | Mar 26, 2025 | Hooks Corwin Dale | Chief Commercial Officer | Neutral | 90.0 | +250,000 | 83.33% | ✗ | - |
| Mar 24, 2025 | Mar 26, 2025 | Funtleyder Leslie D. | Officer | Neutral | 90.0 | +350,000 | 89.64% | ✗ | - |
| Mar 24, 2025 | Mar 26, 2025 | Chinoporos Constantine | Officer | Neutral | 90.0 | +350,000 | 128.94% | ✗ | - |
| Mar 4, 2025 | Mar 6, 2025 | Perfetti Riccardo | Chief Medical Officer | Sell | 47.5 | -10,366 | -1.15% | ✗ | $4.6K |
| Mar 4, 2025 | Mar 6, 2025 | Funtleyder Leslie D. | Officer | Sell | 47.5 | -14,502 | -3.58% | ✗ | $6.4K |
| Mar 4, 2025 | Mar 6, 2025 | Chinoporos Constantine | Officer | Sell | 52.5 | -447 | -0.16% | ✗ | $196.7 |
| Feb 6, 2025 | Feb 7, 2025 | Funtleyder Leslie D. | Officer | Sell | 46.3 | -22,950 | -5.36% | ✗ | $14K |
| Feb 6, 2025 | Feb 7, 2025 | Perfetti Riccardo | Chief Medical Officer | Sell | 42.5 | -86,078 | -8.72% | ✗ | $52.5K |
| Feb 6, 2025 | Feb 7, 2025 | Chinoporos Constantine | Officer | Sell | 46.3 | -28,117 | -9.37% | ✗ | $17.2K |
| Dec 19, 2024 | Dec 20, 2024 | JOHNSON JOHN | Chair | Neutral | 90.0 | +500,000 | 100.00% | ✗ | - |
| Dec 19, 2024 | Dec 20, 2024 | Funtleyder Leslie D. | Officer | Neutral | 90.0 | +150,000 | 53.97% | ✗ | - |
| Dec 20, 2024 | JOHNSON JOHN | Chair | Neutral | 52.5 | - | 0.00% | ✗ | - | |
| Aug 22, 2024 | Aug 23, 2024 | Funtleyder Leslie D. | CFO | Sell | 42.5 | -13,530 | -4.64% | ✗ | $78.9K |
| Aug 22, 2024 | Aug 23, 2024 | Perfetti Riccardo | Chief Medical Officer | Sell | 42.5 | -22,681 | -2.25% | ✗ | $132.2K |
| Aug 5, 2024 | Aug 14, 2024 | Shendelman Shoshana | CEO | Sell | 17.5 | -777,014 | -12.50% | ✗ | $4.7M |
| Jun 6, 2024 | Jun 10, 2024 | Shendelman Shoshana | CEO | Sell | 42.5 | -61,795 | -0.76% | ✗ | $267K |
| Jun 6, 2024 | Jun 10, 2024 | Perfetti Riccardo | Chief Medical Officer | Sell | 42.5 | -22,003 | -2.13% | ✗ | $95.1K |
| Jun 6, 2024 | Jun 10, 2024 | Funtleyder Leslie D. | CFO | Sell | 42.5 | -16,980 | -5.51% | ✗ | $73.4K |
| Jun 6, 2024 | Jun 7, 2024 | Kanter Stacy J. | Director | Neutral | 90.0 | +45,000 | 71.43% | ✗ | - |
| Jun 6, 2024 | Jun 7, 2024 | SKYLER JAY S | Director | Neutral | 90.0 | +45,000 | 225.00% | ✗ | - |
| Jun 6, 2024 | Jun 7, 2024 | MARCUS JOEL S | Director | Neutral | 85.0 | +45,000 | 9.92% | ✗ | - |
| Jun 6, 2024 | Jun 7, 2024 | Lerner Teena | Director | Neutral | 90.0 | +45,000 | 74.48% | ✗ | - |
| Apr 12, 2024 | Apr 15, 2024 | Hooks Corwin Dale | Chief Commercial Officer | Neutral | 90.0 | +300,000 | 100.00% | ✗ | - |
| Apr 15, 2024 | Hooks Corwin Dale | Chief Commercial Officer | Neutral | 52.5 | - | 0.00% | ✗ | - | |
| Mar 14, 2024 | Mar 18, 2024 | Shendelman Shoshana | CEO | Sell | 37.5 | -318,573 | -3.76% | ✗ | $1.7M |
| Mar 14, 2024 | Mar 18, 2024 | Perfetti Riccardo | Chief Medical Officer | Sell | 40.0 | -110,804 | -9.70% | ✗ | $597.2K |
| Mar 14, 2024 | Mar 18, 2024 | Hansard Adam | Chief Commercial Officer | Sell | 40.0 | -48,871 | -6.25% | ✗ | $263.4K |
| Mar 14, 2024 | Mar 18, 2024 | Funtleyder Leslie D. | CFO | Sell | 42.5 | -28,727 | -8.52% | ✗ | $154.8K |
| Dec 28, 2023 | Mar 18, 2024 | Chinoporos Constantine | Officer | Neutral | 90.0 | +300,000 | 100.00% | ✗ | - |
| Mar 18, 2024 | Chinoporos Constantine | Officer | Neutral | 52.5 | - | 0.00% | ✗ | - | |
| Dec 21, 2023 | Dec 22, 2023 | Shendelman Shoshana | CEO | Neutral | 90.0 | +1,540,000 | 22.23% | ✗ | - |
| Dec 21, 2023 | Dec 22, 2023 | Perfetti Riccardo | Chief Medical Officer | Neutral | 90.0 | +450,000 | 65.00% | ✗ | - |
| Dec 21, 2023 | Dec 22, 2023 | Hansard Adam | Chief Commercial Officer | Neutral | 90.0 | +400,000 | 104.77% | ✗ | - |
| Dec 1, 2023 | Dec 5, 2023 | Kanter Stacy J. | Director | Buy | 95.0 | +30,000 | 90.91% | ✗ | $65.4K |
| Nov 30, 2023 | Dec 1, 2023 | Shendelman Shoshana | CEO | Sell | 52.5 | -3,968 | -0.06% | ✗ | $7.8K |
| Nov 30, 2023 | Dec 1, 2023 | Perfetti Riccardo | Chief Medical Officer | Sell | 52.5 | -1,583 | -0.23% | ✗ | $3.1K |
| Nov 30, 2023 | Dec 1, 2023 | Hansard Adam | Chief Commercial Officer | Sell | 52.5 | -965 | -0.25% | ✗ | $1.9K |
| Nov 20, 2023 | Nov 20, 2023 | Funtleyder Leslie D. | CFO | Neutral | 90.0 | +300,000 | 807.58% | ✗ | - |
| Sep 27, 2023 | Sep 29, 2023 | Shendelman Shoshana | CEO | Sell | 40.0 | -115,632 | -1.64% | ✗ | $312.2K |
| Sep 27, 2023 | Sep 29, 2023 | Perfetti Riccardo | Chief Medical Officer | Sell | 46.3 | -10,932 | -1.55% | ✗ | $29.5K |
| Sep 27, 2023 | Sep 29, 2023 | Hansard Adam | Chief Commercial Officer | Sell | 46.3 | -9,720 | -2.48% | ✗ | $26.2K |
| Sep 15, 2023 | Sep 19, 2023 | MARCUS JOEL S | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jun 23, 2023 | Thorpe Catherine | Chief Accounting Officer | Neutral | 52.5 | - | 0.00% | ✗ | - | |
| Jun 6, 2023 | Jun 8, 2023 | SKYLER JAY S | Director | Neutral | 90.0 | +20,000 | 100.00% | ✗ | - |
| Jun 6, 2023 | Jun 8, 2023 | MARCUS JOEL S | Director | Neutral | 82.5 | +20,000 | 4.75% | ✗ | - |
| Jun 6, 2023 | Jun 8, 2023 | Lerner Teena | Director | Neutral | 90.0 | +20,000 | 49.48% | ✗ | - |
| Jun 6, 2023 | Jun 8, 2023 | Kanter Stacy J. | Director | Neutral | 90.0 | +20,000 | 153.85% | ✗ | - |
| Jun 6, 2023 | Jun 8, 2023 | Funtleyder Leslie D. | Director | Neutral | 90.0 | +20,000 | 116.63% | ✗ | - |
| Jan 11, 2023 | Jan 13, 2023 | Shendelman Shoshana | CEO | Sell | 91.3 | +1,948,492 | 38.22% | ✗ | $14.4K |
| Jan 11, 2023 | Jan 13, 2023 | Perfetti Riccardo | Chief Medical Officer | Sell | 90.0 | +543,947 | 338.05% | ✗ | $5.5K |
| Jan 11, 2023 | Jan 13, 2023 | Hansard Adam | Chief Commercial Officer | Sell | 90.0 | +295,505 | 304.74% | ✗ | $4.1K |
| Nov 15, 2022 | Nov 17, 2022 | Ortega Steven A. | Principal Accounting Officer | Neutral | 90.0 | +40,000 | 259.67% | ✗ | - |
| Oct 14, 2022 | Oct 14, 2022 | Shendelman Shoshana | CEO | Buy | 68.8 | +50,000 | 0.99% | ✗ | $32.3K |
| Oct 13, 2022 | Oct 13, 2022 | Shendelman Shoshana | CEO | Buy | 78.8 | +73,256 | 1.47% | ✗ | $40.9K |
| Oct 12, 2022 | Oct 12, 2022 | Shendelman Shoshana | CEO | Buy | 68.8 | +38,153 | 0.77% | ✗ | $19.9K |
| Apr 14, 2021 | Sep 16, 2022 | MARCUS JOEL S | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Sep 14, 2022 | Sep 16, 2022 | MARCUS JOEL S | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Aug 2, 2022 | Aug 4, 2022 | SKYLER JAY S | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Aug 2, 2022 | Aug 4, 2022 | Shendelman Shoshana | CEO | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Aug 2, 2022 | Aug 4, 2022 | Perfetti Riccardo | Chief Medical Officer | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Aug 2, 2022 | Aug 4, 2022 | MARCUS JOEL S | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Aug 2, 2022 | Aug 4, 2022 | Mahadevan Chids | Officer | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Aug 2, 2022 | Aug 4, 2022 | Lerner Teena | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Aug 2, 2022 | Aug 4, 2022 | Kanter Stacy J. | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Aug 2, 2022 | Aug 4, 2022 | Hansard Adam | Chief Commercial Officer | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Aug 2, 2022 | Aug 4, 2022 | Funtleyder Leslie D. | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jun 3, 2022 | Jun 7, 2022 | SKYLER JAY S | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jun 3, 2022 | Jun 7, 2022 | MARCUS JOEL S | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jun 3, 2022 | Jun 7, 2022 | Lerner Teena | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jun 3, 2022 | Jun 7, 2022 | Kanter Stacy J. | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jun 3, 2022 | Jun 7, 2022 | Funtleyder Leslie D. | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| May 16, 2022 | May 18, 2022 | Mahadevan Chids | Officer | Sell | 47.5 | -905 | -8.45% | ✗ | $1.5K |
| Apr 13, 2022 | Apr 15, 2022 | Perfetti Riccardo | Chief Medical Officer | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Apr 13, 2022 | Apr 15, 2022 | Ortega Steven A. | Principal Accounting Officer | Neutral | 90.0 | +3,081 | 25.00% | ✗ | - |
| Apr 13, 2022 | Apr 15, 2022 | Mahadevan Chids | Officer | Neutral | 90.0 | +2,136 | 24.93% | ✗ | - |
| Apr 13, 2022 | Apr 15, 2022 | Hansard Adam | Chief Commercial Officer | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Mar 21, 2022 | Mar 23, 2022 | Perfetti Riccardo | Chief Medical Officer | Buy | 95.0 | +64,509 | 66.92% | ✗ | $125.8K |
| Mar 18, 2022 | Ortega Steven A. | Principal Accounting Officer | Neutral | 52.5 | - | 0.00% | ✗ | - | |
| Jan 25, 2022 | Jan 27, 2022 | Shendelman Shoshana | CEO | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jan 7, 2022 | Jan 11, 2022 | Silberstein Charles | CFO | Neutral | 90.0 | +47,900 | 35.30% | ✗ | - |
| Jan 7, 2022 | Jan 11, 2022 | Shendelman Shoshana | CEO | Neutral | 82.5 | +120,900 | 2.51% | ✗ | - |
| Jan 7, 2022 | Jan 11, 2022 | Perfetti Riccardo | Chief Medical Officer | Neutral | 90.0 | +48,200 | 100.00% | ✗ | - |
| Jan 7, 2022 | Jan 11, 2022 | Hansard Adam | Chief Commercial Officer | Neutral | 90.0 | +31,700 | 48.57% | ✗ | - |
| Dec 14, 2021 | Jan 11, 2022 | Silberstein Charles | CFO | Neutral | 90.0 | +47,900 | 54.55% | ✗ | - |